|
Jill Rasmussen, MBChB, MRCGP,
FFPM
(England, United Kingdom),
Treasurer
Dr. Rasmussen obtained her medical degree
in Manchester in 1972 and began her medical
career with a residency focussed on primary
care. During the early eighties, she
developed an interest in clinical research
that culminated in her joining the
pharmaceutical industry in 1983 where she
was mainly involved in clinical development
of therapeutics in psychiatry and neurology
initially in Europe and later for four years
in the US. This experience made her acutely
aware of the tensions between patients’
needs and pharmaceutical interests and the
need to improve communication between the
two. In addition, she experienced the
regulatory view as a medical assessor in the
UK Medicines Control Agency, which
reinforced her view that patient needs will
best be served less by company and
bureaucratic isolation and more by genuine
dialogue.
In 1994, Dr. Rasmussen rejoined the National
Health Service and simultaneously set up an
independent CNS consultancy, psynapse, which
was and remains staffed by her, her husband
and administrative support. In the NHS, she
is a primary care specialist in learning
disability and psychiatric illness in adults
and elderly.
In her company, psynapse, Dr. Rasmussen
offers strategic advice to developers of CNS
therapeutics, assists venture capital banks
with “due diligence” assessments of
proposals for investment in CNS therapeutic
development and works with various groups to
develop educational and e-learning materials
for patients, primary care workers and
specialists in psychiatric and neurological
disorders. She is also a member of the
Scientific Advisory Board of a number of
pharma and biotech companies. Since 2003,
she has been a council member of the British
Association of Psychopharmacology. She is
also a Director of the UK National
Neuroscience Research Institute.
Dr. Rasmussen has served on the Board of
Directors since 2004. She can be reached at Jill.Rasmussen@psynapse-consulting.com.
-
Return to previous page.
|
